StockData
Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc. (HEPA) stock

HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)

Close on Oct 19, 2026Market cap $7.26MP/E –Yield –

Hepion Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Hepion Pharmaceuticals's cash was $4.26M at Sep 30, 2026. For fiscal 2025 it was $1.83M, up 349.8% from the year before. Over ten years it grew 0.1% a year on average. The highest annual figure on record is $91.35M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.83M+349.8%
FY2024Dec 31, 2024$406.41K-97.3%
FY2023Dec 31, 2023$14.79M-71.1%
FY2022Dec 31, 2022$51.19M-44.0%
FY2021Dec 31, 2021$91.35M+124.3%
FY2020Dec 31, 2020$40.73M+192.5%
FY2019Dec 31, 2019$13.92M+7.2%
FY2017Jun 30, 2017$12.98M+75.3%
FY2016Jun 30, 2016$7.40M+62.3%
FY2015Jun 30, 2015$4.56M+151.0%
FY2014Jun 30, 2014$1.82M+1996.2%
FY2013Jun 30, 2013$86.72K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ3 2026Sep 30, 2026$4.26M+83.3%
Q2 FY2026CQ2 2026Jun 30, 2026$1.63M-44.3%
Q1 FY2026CQ1 2026Mar 31, 2026$2.60M-43.3%
Q4 FY2025CQ4 2025Dec 31, 2025$1.83M+349.8%
Q3 FY2025CQ3 2025Sep 30, 2025$2.32M+55.0%
Q2 FY2025CQ2 2025Jun 30, 2025$2.92M+38.3%
Q1 FY2025CQ1 2025Mar 31, 2025$4.59M-65.0%
Q4 FY2024CQ4 2024Dec 31, 2024$406.41K-97.3%
Q3 FY2024CQ3 2024Sep 30, 2024$1.50M-92.2%
Q2 FY2024CQ2 2024Jun 30, 2024$2.12M-93.1%
Q1 FY2024CQ1 2024Mar 31, 2024$13.11M-69.5%
Q4 FY2023CQ4 2023Dec 31, 2023$14.79M-71.1%
Q3 FY2023CQ3 2023Sep 30, 2023$19.28M-67.4%
Q2 FY2023CQ2 2023Jun 30, 2023$30.52M-57.4%
Q1 FY2023CQ1 2023Mar 31, 2023$42.99M-45.7%
Q4 FY2022CQ4 2022Dec 31, 2022$51.19M-44.0%
Q3 FY2022CQ3 2022Sep 30, 2022$59.15M-40.1%
Q2 FY2022CQ2 2022Jun 30, 2022$71.71M-34.9%
Q1 FY2022CQ1 2022Mar 31, 2022$79.22M-31.4%
Q4 FY2021CQ4 2021Dec 31, 2021$91.35M+124.3%
Q3 FY2021CQ3 2021Sep 30, 2021$98.73M+620.1%
Q2 FY2021CQ2 2021Jun 30, 2021$110.09M+526.9%
Q1 FY2021CQ1 2021Mar 31, 2021$115.45M+619.4%
Q4 FY2020CQ4 2020Dec 31, 2020$40.73M+192.5%
Q3 FY2020CQ3 2020Sep 30, 2020$13.71M-7.8%
Q2 FY2020CQ2 2020Jun 30, 2020$17.56M+2.4%
Q1 FY2020CQ1 2020Mar 31, 2020$16.05M+853.7%
Q4 FY2019CQ4 2019Dec 31, 2019$13.92M+7.2%
Q3 FY2019CQ3 2019Sep 30, 2019$14.86M+142.2%
Q2 FY2019CQ2 2019Jun 30, 2019$17.15M+62.5%
Q1 FY2019CQ1 2019Mar 31, 2019$1.68M-44.4%
Q4 FY2017CQ2 2017Jun 30, 2017$12.98M+75.3%
Q3 FY2017CQ1 2017Mar 31, 2017$6.14M+3.0%
Q2 FY2017CQ4 2016Dec 31, 2016$10.55M+7.3%
Q1 FY2017CQ3 2016Sep 30, 2016$3.03M+69.1%
Q4 FY2016CQ2 2016Jun 30, 2016$7.40M+62.3%
Q3 FY2016CQ1 2016Mar 31, 2016$5.96M–
Q2 FY2016CQ4 2015Dec 31, 2015$9.83M–
Q1 FY2016CQ3 2015Sep 30, 2015$1.79M–
Q4 FY2015CQ2 2015Jun 30, 2015$4.56M–

More Hepion Pharmaceuticals figures

See a number that looks wrong?